Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
Guardado en:
Autores principales: | Jalil Rashedi, Behroz Mahdavi Poor, Mohammad Asgharzadeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/73f9fdb804c74f04a426f58cee39bf3c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Letter to the editor regarding ‘‘Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia’
por: Donna Zarzuela, PharmD, et al.
Publicado: (2021) -
Commentary of the mRNA vaccines COVID-19
por: Antonio Vitiello, et al.
Publicado: (2021) -
Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers
por: Kawabata M, et al.
Publicado: (2015) -
A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
por: Ata Mahmoodpoor, et al.
Publicado: (2020) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Lennox Chitsike, et al.
Publicado: (2021)